Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Extension of DS-5565 in Fibromyalgia
NCT02234583Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of mirogabalin in fibromyalgia (FM), sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 2015; status: completed.
02
Drugs
mirogabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02234583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234583.